sirolimus and Budd-Chiari-Syndrome

Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy. This association has been reported less frequently with tacrolimus.. We present an 11-year old male with Budd-Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to sirolimus.. Since these drugs are used widely in the pediatric transplantation population, this report serves to heighten awareness of this debilitating phenomenon, and to stress the importance of exercising caution when sirolimus and tacrolimus are administered in combination to pediatric patients.

Topics: Administration, Oral; Budd-Chiari Syndrome; Calcineurin Inhibitors; Child; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Protein Serine-Threonine Kinases; Severity of Illness Index; Sirolimus; Stomatitis, Aphthous; Tongue Diseases; TOR Serine-Threonine Kinases